Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 47139.53 Crore) operating in Pharmaceuticals sector.
Trading volume on the counter was almost three times higher than its two-week average trading volume on BSE. Over 5.25 million shares changed hands till 1.15 pm on both BSE and NSE.
June 02, 2021
Possible demerger could unlock value, says Edelweiss
The scrip of ITC closed at ₹209.05 on Wednesday, about 3 per cent lower, at the NSE, despite most analysts remaining bullish on the stock after the company came out with Q4 results that met their expectations.
Diversified conglomerate ITC reported an over one per cent drop in standalone net profit for the quarter ended March 31, 2021, to ₹3,748 crore.
Most brokerages such as Morgan Stanley, Jefferies, Emkay Global Financial Services, Yes Securities, IDBI Securities, Prabhudas Lilladher and Centrum Broking have maintained their positive stance on the company while others still remain cautious on the stock.
Yes Securities has buy call on
Dilip Buildcon with a target price of Rs 663. The current market price of Dilip Buildcon Ltd. is Rs 545.1. Time period given by analyst is 1 year when Dilip Buildcon price can reach defined target.
Dilip Buildcon Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7905.84 Crore) operating in Construction sector. Dilip Buildcon Ltd. key Products/Revenue Segments include Contract Revenue and Other Operating Revenue for the year ending 31-Mar-2020.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 3143.48 Crore, up 13.94 % from last quarter Total Income of Rs 2758.93 Crore and up 14.71 % from last year same quarter Total Income of Rs 2740.47 Crore. Company reported net profit after tax of Rs 168.76 Crore in latest quarter.